Biocompatible Nanomaterials for Targeted and Controlled Delivery of Biomacromolecules
Download citation file:
- Ris (Zotero)
- Reference Manager
In 2006, United States Food and Drugs Administration (FDA) included nanotechnology in its Critical Task Force and formed a Nanotechnology Task Force to determine the regulatory approaches that would enable to continue the development of innovative, safe and effective FDA-regulated products, which use nanoscale materials (http://www.fda.gov/nanotechnology/). In July of 2007, the task force released its first nanotechnology report in which the task force highlighted scientific and regulatory issues involving nanoscale material containing products. The scientific issues were focused on understanding the interactions of nanoscale materials with biological systems and the adequacy of current testing approaches for assessing safety and quality of products containing nanoscale materials .